Devices › Catheter, embolectomy
Device brand name · Catheter embolectomy
Fogarty Arterial Embolectomy Catheter: medical device reports filed with FDA
1,165 reports name it, 1993–2026. Manufacturer given most often on reports: Edwards Lifesciences Pr. Product code DXE.
- 1,165
- device reports naming the brand
- 0% of all MAUDE reports · about 35 a year
- 37
- reports, 12 months to August 2026
- 13 in the 12 months before
- 87.4%
- classified as malfunction
- 80.1% across the product code
- 0.2%
- classified as death, as reported
- 2 reports · not verified by FDA
1,165 medical device reports received by FDA name the brand "Fogarty Arterial Embolectomy Catheter" (catheter embolectomy); the manufacturer given most often on reports is Edwards Lifesciences Pr; received from February 1993 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
37 reports arrived in the 12 months to August 2026, up 185% from 13 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (87.4%), other (9.1%) and injury (3.1%); across all catheter, embolectomy reports (product code DXE) death is recorded in 1.8% and malfunction in 80.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are material fragmentation (27%), material rupture (11.8%) and detachment of device component (11.2%). The patient problems coded most often are foreign body, removal of, nonresorbable materials, unretrieved in body and surgical procedure, additional. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 7,789 reports carrying product code DXE. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Material fragmentation | 315 | 27% | 5.7% |
| Material rupture | 138 | 11.8% | 11.8% |
| Detachment of device component | 131 | 11.2% | 4.9% |
| Deflation problem | 100 | 8.6% | 3.9% |
| Material separation | 74 | 6.4% | 5.7% |
| Breakthe device broke | 72 | 6.2% | 12.7% |
| Detachment of device or device componentpart of the device came off | 69 | 5.9% | 3.8% |
| Device damaged prior to receipt by user | 51 | 4.4% | 1% |
| Burst container or vessel | 48 | 4.1% | 2.1% |
| Balloon rupture | 33 | 2.8% | 1.1% |
| Material disintegration | 30 | 2.6% | 0.4% |
| Tip breakage | 22 | 1.9% | 2% |
| Material puncture/hole | 20 | 1.7% | 0.8% |
| Inflation problem | 19 | 1.6% | 0.9% |
| Balloon burst | 17 | 1.5% | 0.6% |
| Device, or device fragments remain in patient | 16 | 1.4% | 1.5% |
| Difficult to removethe device was hard to remove | 15 | 1.3% | 2.6% |
| Replace | 15 | 1.3% | 0.8% |
| Component missing | 13 | 1.1% | 0.5% |
| Fracturea broken bone | 10 | 0.9% | 1.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Foreign body, removal of | 33 | 2.8% |
| Nonresorbable materials, unretrieved in body | 18 | 1.5% |
| Surgical procedure, additional | 16 | 1.4% |
| Device embedded in tissue or plaque | 15 | 1.3% |
| No patient involvement | 15 | 1.3% |
| Foreign body in patientpart of a device left in the patient | 13 | 1.1% |
| Therapy/non-surgical treatment, additional | 12 | 1% |
| Surgical procedure | 10 | 0.9% |
| Other (for use when an appropriate patient code cannot be identified) | 8 | 0.7% |
| Blood loss | 5 | 0.4% |
| Ischemia | 5 | 0.4% |
| Surgery, prolonged | 5 | 0.4% |
| Occlusion | 4 | 0.3% |
| Painpain, site not specified | 4 | 0.3% |
| Embolism/embolus | 3 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Fogarty Arterial Embolectomy Catheter | Product code DXE | All MAUDE reports |
|---|---|---|---|
| Reports | 1,165 | 7,789 | 26,136,888 |
| Share of that pool | — | 15% | 0% |
| Classified as death, per 1,000 reports | 2 | 18 | 9 |
| Classified as injury | 3.1% | 14.4% | 36.2% |
| Classified as malfunction | 87.4% | 80.1% | 62.3% |
| Filed by the manufacturer | 97.9% | 93% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DXE
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| AngioJet SOLENT omni | 671 | 26 | 1.3% |
| Fogarty Thru-Lumen Embolectomy Catheter | 427 | 76 | 0.7% |
| Indigo System Aspiration Catheter 6 | 472 | 0 | 0% |
| TufTex Over-the-Wire Embolectomy Catheter | 361 | 159 | 0% |
| Angiojet Zelantedvt | 304 | 0 | 5.3% |
| Indigo System Aspiration Catheter 8 | 196 | 2 | 1.5% |
| Indigo System Separator 8 | 157 | 4 | 1.9% |
| Indigo System Catrx Aspiration Catheter | 259 | 11 | 0% |
| AngioJet SOLENT Proxi | 175 | 5 | 4.6% |
| AdvanCE | 220 | 8 | 2.7% |
| Pruitt F3 Carotid Shunt | 395 | 73 | 0.3% |
| Internal Hex Implant | 2,074 | 0 | 0% |
| Galileo | 701 | 0 | 0.1% |
| Penumbra System Jet7 Reperfusion Catheter | 379 | 0 | 4% |
| Ruby Coil | 3,360 | 26 | 0.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Fogarty Arterial Embolectomy Catheter reports
How many FDA reports name Fogarty Arterial Embolectomy Catheter?
1,165 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 37 in the latest 12 months.
What kinds of events are reported?
malfunction (87.4%), other (9.1%) and injury (3.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
material fragmentation (27%), material rupture (11.8%), detachment of device component (11.2%), deflation problem (8.6%) and material separation (6.4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (97.9%) and voluntary reports (0.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Fogarty Arterial Embolectomy Catheter was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.